Zemirciclib

N/A

Report date: 2026/01/08 09:20:58
NME

Base Information

Drug NameZemirciclib
Drug Alias NameAZD-4573
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin-dependent kinase 9 inhibitors
TargetsCyclin-dependent kinase 9
Therapy Area/IndicationsRichter's SyndromeMyelodysplastic SyndromesHematologic Neoplasms +[12
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesSweden +[15
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaDiscontinued
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsRichter's SyndromeMyelodysplastic SyndromesHematologic Neoplasms +[12

Other Information

ATC CodeN/A
Related LinksN/A